SHARE CAPITAL |
7. SHARE CAPITAL Authorized The Company’s share capital consists of an unlimited number of authorized common shares without par value. At December 31, 2023 and 2022, there were 195,885,531 and 195,313,184 shares issued and outstanding, respectively. Share issuances At the Company’s 2023 Annual General Meeting of Shareholders held on May 23, 2023, Mr. Stephen Lang did not stand for re-election as director. On June 22, 2023, in accordance with the approved Deferred Share Unit Plan, the Company issued 572,347 common shares to Mr. Lang and transferred related contributed surplus of $381,238 to share capital. During the year ended December 31, 2022, the Company issued 405,000 common shares pursuant to the exercise of stock options for total proceeds of $290,290 and transferred related contributed surplus of $162,479 to share capital. Stock options The Company adopted an incentive stock option plan in 2006, as amended September 19, 2012 and re-approved by the Company’s shareholders on May 28, 2015, May 30, 2018, and May 25, 2021 (the “Stock Option Plan”). The essential elements of the Stock Option Plan provide that the aggregate number of common shares of the Company that may be issued pursuant to options granted under the Stock Option Plan and any other share-based compensation arrangements may not exceed 10% of the number of issued shares of the Company at the time of the granting of options. Options granted under the Stock Option Plan will have a maximum term of ten years. The exercise price of options granted under the Stock Option Plan shall be fixed in compliance with the applicable provisions of the Toronto Stock Exchange (“TSX”) Company Manual in force at the time of grant and, in any event, shall not be less than the closing price of the Company’s common shares on the TSX on the trading day immediately preceding the day on which the option is granted, or such other price as may be agreed to by the Company and accepted by the TSX. Options granted under the Stock Option Plan vest immediately, unless otherwise determined by the directors at the date of grant. During the year ended December 31, 2023, the Company granted a total of 240,000 incentive stock options to certain officers and employees of the Company to purchase common shares in the capital stock of the Company at an issue price of C$0.63 per share. Of the total 240,000 stock options granted, 150,000 were granted to Mr. Karl Hanneman, Chief Executive Officer. All of the options vest one-third on the grant date, one-third on May 23, 2024, one-third on May 23, 2025 and expire on May 23, 2029. During the year ended December 31, 2022, the Company granted a total of 240,000 incentive stock options to certain officers and employees of the Company to purchase common shares in the capital stock of the Company at an issue price of C$0.92 per share. Of the total 240,000 stock options granted, 150,000 were granted to Mr. Karl Hanneman, Chief Executive Officer. All of the options vest one-third on the grant date, one-third on May 24, 2023, one-third on May 24, 2024 and expire on May 24, 2028. A summary of the status of the stock option plan as of December 31, 2023 and 2022 and changes during the fiscal years is presented below: | | | | | | | | | | | | | | | | | | | | Year Ended | | | Year Ended | | | December 31, 2023 | | | December 31, 2022 | | | | | Weighted | | | | | | | | Weighted | | | | | | | | Average | | Aggregate | | | | | Average | | Aggregate | | | Number of | | Exercise | | Intrinsic | | | Number of | | Exercise | | Intrinsic | | | Options | | Price (C$) | | Value (C$) | | | Options | | Price (C$) | | Value (C$) | | | | | | | | | | | | | | | | | | | Balance, beginning of the year | | 2,287,049 | | $ | 0.95 | | | — | | | 2,947,049 | | $ | 0.97 | | | — | Granted | | 240,000 | | $ | 0.63 | | | — | | | 240,000 | | $ | 0.92 | | | — | Exercised | | — | | | — | | | — | | | (405,000) | | $ | 0.90 | | | — | Expired | | (740,000) | | $ | 0.91 | | | — | | | (495,000) | | $ | 1.08 | | | — | Balance, end of the year | | 1,787,049 | | $ | 0.92 | | $ | 93,571 | | | 2,287,049 | | $ | 0.95 | | $ | 10,400 |
The weighted average remaining life of options outstanding at December 31, 2023 was 2.5 years. Stock options outstanding are as follows: | | | | | | | | | | | | | | | | | | December 31, 2023 | | | December 31, 2022 | | | Exercise | | Number of | | | | | Exercise | | Number of | | | Expiry Date | | Price (C$) | | Options | | Exercisable | | | Price (C$) | | Options | | Exercisable | March 16, 2023 | | | — | | — | | — | | | $ | 1.00 | | 580,000 | | 580,000 | March 16, 2023 | | | — | | — | | — | | | $ | 0.50 | | 130,000 | | 130,000 | June 9, 2023 | | | — | | — | | — | | | $ | 1.00 | | 30,000 | | 30,000 | March 21, 2024 | | $ | 0.61 | | 374,817 | | 374,817 | | | $ | 0.61 | | 374,817 | | 374,817 | February 1, 2025 | | $ | 1.35 | | 250,000 | | 250,000 | | | $ | 1.35 | | 250,000 | | 250,000 | August 8, 2025 | | $ | 0.85 | | 187,232 | | 187,232 | | | $ | 0.85 | | 187,232 | | 187,232 | May 27, 2026 | | $ | 0.92 | | 255,000 | | 255,000 | | | $ | 0.92 | | 255,000 | | 255,000 | May 25, 2027 | | $ | 1.31 | | 240,000 | | 240,000 | | | $ | 1.31 | | 240,000 | | 160,000 | May 24, 2028 | | $ | 0.92 | | 240,000 | | 160,000 | | | $ | 0.92 | | 240,000 | | 80,000 | May 23, 2029 | | $ | 0.63 | | 240,000 | | 80,000 | | | | — | | — | | — | | | | — | | 1,787,049 | | 1,547,049 | | | | — | | 2,287,049 | | 2,047,049 |
A summary of the non-vested options as of December 31, 2023 and 2022 and changes during the fiscal years ended December 31, 2023 and 2022 is as follows: | | | | | | | | | | Weighted average | | | | | grant-date fair | Non-vested options: | | Number of options | | value (C$) | Outstanding at December 31, 2021 | | 245,000 | | $ | 0.91 | Granted | | 240,000 | | $ | 0.60 | Vested | | (245,000) | | $ | 0.78 | Outstanding at December 31, 2022 | | 240,000 | | $ | 0.73 | Granted | | 240,000 | | $ | 0.42 | Vested | | (240,000) | | $ | 0.67 | Outstanding at December 31, 2023 | | 240,000 | | $ | 0.48 |
At December 31, 2023, there was C$46,265 of unrecognized compensation expense related to non-vested options outstanding. Deferred Share Unit Incentive Plan On April 4, 2017, the Company adopted a Deferred Share Unit Plan (the “DSU Plan”). The DSU Plan was approved by the Company’s shareholders on May 24, 2017 and re-approved by the Company’s shareholders on May 27, 2020 and May 25, 2021. As at December 31, 2023, the maximum aggregate number of common shares that could be issued under the DSU Plan and the Stock Option Plan was 19,588,553, representing 10% of the number of issued and outstanding common shares on that date (on a non-diluted basis). As at December 31, 2023, the Company had stock options to potentially acquire 1,787,049 common shares outstanding under the Stock Option Plan (representing approximately 0.91% of the outstanding common shares), leaving up to 17,801,504 common shares available for future grants under the DSU Plan and under the Stock Option Plan (combined) based on the number of outstanding common shares as at that date on a non-diluted basis (representing an aggregate of approximately 9.09% of the outstanding common shares). During the year ended December 31, 2023, in accordance with the DSU Plan, the Company granted each of the members of the Board as of May 23, 2023 (other than those directors nominated for election by Paulson & Co. Inc.) 131,746 DSUs for a total of 526,984 DSUs with a grant date fair value (defined as the weighted average of the prices at which the common shares traded on the exchange with the most volume for the five trading days immediately preceding the grant) of C$0.63 per DSU, representing C$83,000 per director or C$332,000 in the aggregate. On July 12, 2023, in accordance with the DSU Plan, the Company granted a new member of the Board 145,614 DSUs with a grant date fair value (defined as the weighted average of the prices at which the common shares traded on the exchange with the most volume for the five days immediately preceding the grant) of C$0.57 per DSU, representing C$83,000. During the year ended December 31, 2022, in accordance with the DSU Plan, the Company granted each of the members of the Company’s Board of Directors (other than those directors nominated for election by Paulson & Co. Inc.) 90,217 DSUs for a total of 451,085 DSUs with a grant date fair value (defined as the weighted average of the prices at which the common shares traded on the exchange with the most volume for the five trading days immediately preceding the grant) of C$0.92 per DSU, representing C$83,000 per director or C$415,000 in the aggregate. The DSUs entitle the holders to receive common shares of the Company’s stock without the payment of any consideration. The DSUs vested immediately upon being granted, but the common shares of stock underlying the DSUs are not deliverable to the grantee until the grantee is no longer serving on the Company’s Board of Directors. DSUs outstanding are as follows: | | | | | | | | | | | | | | Year Ended | | | Year Ended | | | December 31, 2023 | | | December 31, 2022 | | | | | Weighted average | | | | | Weighted average | | | Number of | | grant-date fair | | | Number of | | grant-date fair | | | DSUs | | value (C$) | | | DSUs | | value (C$) | Balance, beginning of the year | | 2,602,361 | | $ | 0.89 | | | 2,151,276 | | $ | 0.88 | Issued | | 672,598 | | $ | 0.62 | | | 451,085 | | $ | 0.92 | Delivered | | (572,347) | | $ | 0.87 | | | — | | | — | Balance, end of the year | | 2,702,612 | | $ | 0.83 | | | 2,602,361 | | $ | 0.89 |
Share-based payments During the year ended December 31, 2023, the Company granted 240,000 stock options and 672,598 DSUs. Share-based payment compensation for the year ended December 31, 2023 total $415,186 ($91,382 related to stock options and $323,804 related to DSUs). Of the total expense for the year ended December 31, 2022, $329,515 was included in consulting fees, $79,960 was included in wages and benefits, and $5,711 was included in investor relations in the statement of operations and comprehensive loss. During the year ended December 31, 2022, the Company granted 240,000 stock options and 451,085 DSUs. Share-based payment compensation for the year ended December 31, 2022 total $448,474 ($135,451 related to stock options and $313,023 related to DSUs). Of the total expense for the year ended December 31, 2022, $322,052 was included in consulting fees, $117,994 was included in wages and benefits, and $8,428 was included in investor relations in the statement of operations and comprehensive loss. The following weighted average assumptions were used for the Black-Scholes option pricing model of the stock options: | | | | | | | | | | Year Ended | | Year Ended | | | | December 31, | | December 31, | | | | 2023 | | 2022 | | Expected life of options | | | 6 years | | | 6 years | | Risk-free interest rate | | | 3.29 | % | | 2.64 | % | Expected volatility | | | 74.39 | % | | 76.75 | % | Dividend rate | | | 0.00 | % | | 0.00 | % | Exercise price (C$) | | $ | 0.63 | | $ | 0.92 | |
The expected volatility used in the Black-Scholes option pricing model is based on the historical volatility of the Company’s shares.
|